# Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition

> **NCT02859792** · PHASE2 · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 90 (estimated)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Riluzole
- **DRUG:** Placebo
- **BIOLOGICAL:** Blood Samples

## Key facts

- **NCT ID:** NCT02859792
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-27
- **Primary completion:** 2023-11
- **Final completion:** 2023-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859792, "Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02859792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*